Sore Throat News and Research

RSS

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

Study shows only 75.8% of children under 15 have antibodies against measles

A study conducted in Brazil and reported in an article in Vaccines shows that in the São José do Rio Preto region in the northwest of São Paulo state, only 75.8% of children aged 0-15 have antibodies against measles.

1 Dec 2022

Addiction treatment proponents urge rural clinicians to pitch in by prescribing medication

Andrea Storjohann is glad to see that she's becoming less of a rarity in rural America.

1 Dec 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Omicron BA.2 causes more symptoms and a greater disruption to daily life

In a recent study published in the Nature Communications journal, researchers monitored the changing symptom profiles associated with different severe acute respiratory syndrome CoV-2 (SARS-CoV-2) variants, especially Omicron subvariants BA.1 and BA.2.

16 Nov 2022

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

In a recent study posted to the medRxiv* server, researchers evaluated non-invasive transcutaneous vagus nerve stimulation [tVNS] as a treatment for long COVID-related chronic fatigue syndrome (CFS).

10 Nov 2022

What are the eye complications associated with monkeypox infection?

A new study describes the association between monkeypox infection and eye complications in humans.

9 Nov 2022

New Pathogen Analyzer combines the advantages of PCR and rapid antigen testing

Speed or accuracy? As far as COVID-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.

2 Nov 2022

Exploring the safety and immunogenicity of KD-414, a novel SARS-CoV-2 vaccine

In a new study, researchers assessed the immunogenicity and safety of KD-414, an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.

1 Nov 2022

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

A new study evaluated the effect of ivermectin on time to recovery from coronavirus disease 2019 (COVID-19) in patients with mild to moderate disease.

25 Oct 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

COVID-19 vaccination reduced the severity of the Omicron-driven pandemic wave in Saudi Arabia

In a new study, researchers conducted a retrospective study of all COVID-19 cases from a single hospital in the Kingdom of Saudi Arabia (KSA) between December 25, 2021, and February 30, 2022.

14 Oct 2022

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Findings of a new study depicted that fully vaccinated patients suffering from systemic autoimmune rheumatic diseases harbor a lower propensity to developing long COVID symptoms compared to SARDs patients who are not fully vaccinated.

11 Oct 2022

The extent of long COVID and its characteristics among the older population

Researchers explored the characteristics of long COVID among older adults.

5 Oct 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Uganda confirms seven cases of Ebola and one death

Health authorities in Uganda have recently announced an Ebola Virus Disease outbreak in Mubende District, Uganda.

22 Sep 2022

Neutralizing antibody responses, breakthrough SARS-CoV-2 infections, and symptoms after booster BNT162b2 COVID-19 vaccinations

A new study evaluated neutralizing antibody (nAb) responses against the SARS-CoV-2 Omicron variant induced by booster vaccination with Pfizer-BioNTech’s BNT162b2 messenger ribonucleic acid vaccine.

20 Sep 2022

Monkeypox virus infection in an immunocompromised patient

Researchers assessed the manifestations of the monkeypox infection in an immunocompromised patient.

19 Sep 2022

What is the effect of the Omicron variant on olfaction?

A new study discusses the effect of the Omicron variant of the virus on the olfactory system in humans.

15 Sep 2022